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a b s t r a c t
Xenopus cadherin-11 (Xcadherin-11) is an exceptional cadherin family member, which is predominantly
expressed in cranial neural crest cells (NCCs). Apart from mediating cell–cell adhesion it promotes cranial
NCC migration by initiating ﬁlopodia and lamellipodia formation. Here, we demonstrate an unexpected
function of Xcadherin-11 in NCC speciﬁcation by interfering with canonical Wnt/β-catenin signaling. Loss-of-
function experiments, using a speciﬁc antisense morpholino oligonucleotide against Xcadherin-11, display a
nuclear β-catenin localization in cranial NCCs and a broader expression domain of the proto-oncogene cyclin
D1 which proceeds c-myc up-regulation. Additionally, we observe an enhanced NCC proliferation and an
expansion of speciﬁc NCC genes like AP2 and Sox10. Thereby, we could allocate NCC proliferation and
speciﬁcation to different gene functions. To clarify which domain in Xcadherin-11 is required for early NCC
development we tested different deletion mutants for their rescue ability in Xcadherin-11 morphants. We
identiﬁed the cytoplasmic tail, speciﬁcally the β-catenin binding domain, to be necessary for proper NCC
development. We propose that Xcadherin-11 is necessary for controlled NCC proliferation and early NCC
speciﬁcation in tuning the expression of the canonical Wnt/β-catenin target genes cyclin D1 and c-myc by
regulating the concentration of the nuclear pool of β-catenin.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Neural crest cells (NCCs) are a multipotent stem cell population
in vertebrates giving rise to a variety of cell types including glia cells
and neurons of the peripheral nervous system, cartilage and bone of
the craniofacial structures and pigment cells of the skin (Hall and
Hörstadius, 1988; le Douarin and Kalcheim, 1999). The induction of
NCCs starts at early gastrula stages at the lateral edges of the neural
plate by formation of deﬁned morphogen levels like BMP, Wnt,
retinoic acid (RA), FGF and Notch signaling by which NC speciﬁcation
is activated (Basch et al., 2004; Steventon et al., 2005). In particular,
there is strong evidence that the canonical Wnt/β-catenin pathway
plays a direct role in the induction of NCCs. In Xenopus, depletion of
the Wnt receptor Frizelled3, over-expression of the Wnt antagonist
GSK3β or the over-expression of a dominant-negative Wnt ligand
inhibits NCC formation (Saint-Jeannet et al., 1997; LaBonne and
Bronner-Fraser, 1998; Deardorff et al., 2001). Furthermore, De Calisto
et al. (2005) showed that a Disheveled mutant disrupting the
canonical Wnt/β-catenin pathway led to a strong inhibition of NCC
induction. Additionally, the Lef/TCF transcription factors, which are
the nuclear mediators of the canonical Wnt/β-catenin pathway, bind
and regulate the promotor of Slug, which is an early marker of NCCs
(Vallin et al., 2001).
The proto-oncogene c-myc, a basic helix-loop-helix zipper
(bHLHZ) transcription factor, is a downstream target of Wnt-
signaling in early embryonic carcinoma cells and colorectal tumors
(He et al., 1998; Willert et al., 2002). It plays a role in different
cellular events, such as proliferation, differentiation, cell growth
and apoptosis. During NCC induction c-myc is expressed at the
neural plate border and is one of the earliest NCC speciﬁers. Loss of
function experiments revealed that c-myc is required for the initial
induction of neural crest precursors independent upon changes in
cell proliferation or cell death (Bellmeyer et al., 2003). Cyclin D1 is
another target of the canonical Wnt/β-catenin pathway and is
over-expressed in many colon carcinomas (Shtutman et al., 1999;
Tetsu and McCormick, 1999). It is one of the main regulators of the
GI to S-phase transition during the proliferative stage of the cell
cycle (Baldin et al., 1993; Sherr, 1996). In the Xenopus embryo,
cyclin D1 expression starts at the onset of gastrulation. During
neurulation and tailbud stages transcripts are mainly localized in
anterior domains like the developing eye, brain, neural tube and
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migrating NCCs (Vernon and Philpott, 2003). Promotor analysis
revealed that its neural plate speciﬁc expression depends on a
putative Lef/TCF binding site (Tanaka et al., 2003).
β-catenin has a dual role within the cell. Besides its function as
an essential effector of the canonical Wnt-signaling pathway, β-
catenin is localized at cell–cell adhesion complexes connecting
cadherins to the actin cytoskeleton (Ozawa et al., 1989). Cadherins
represent a multigene family of Ca2þ-dependent glycoproteins
mediating cell–cell adhesion processes. Apart from the establish-
ment of an epithelial cell polarization and the formation of robust
cell–cell contacts, the zonula adherens, cadherins are responsible
for cell proliferation as well as for the transfer of signals for cell
differentiation (Takeichi, 1995; Geiger and Ayalon, 1992; Wollner
et al., 1992). Classical cadherins consist of three domains, an
extracellular domain mediating cell–cell adhesion via a zipper like
mechanism, a hydrophobic transmembrane domain and a highly
conserved cytoplasmic tail. This cytoplasmic domain is linked to
the cytoskeleton by β-catenin and α-catenin to generate force
within the cell (Gumbiner, 2000; Jamora and Fuchs, 2002). The
role of E-cadherin is intensively investigated. Besides its function
in an adhesive complex, E-cadherin can sequester β-catenin away
from the nucleus acting as a tumor suppressor (Gottardi et al.,
2001; Stockinger et al., 2001). Furthermore, the loss of E-cadherin
is correlated with the invasion of epithelial tumor cells (Cavallaro
and Christofori, 2004). Recently it was shown, that downregula-
tion of E-cadherin activates β-catenin/TCF dependent transcrip-
tion, which subsequently leads to the expression of invasion
promoting genes like c-myc (Wang et al., 2010).
The mesenchymal cadherin-11 is highly expressed in prostate
and breast cancer cells, where it leads to an accelerated invasion
(Bussemakers et al., 2000; Tomita et al., 2000; Pishvaian et al.,
1999). Additionally, cadherin-11 is involved in triggering inﬂam-
matory arthritis, where cells covering the joint capsule colonize
the bone (Chang et al., 2010). During Xenopus embryogenesis
cadherin-11 (Xcadherin-11) is mainly expressed in the migrating
NCCs (Borchers et al., 2001). Gain of function analysis revealed that
Xcadherin-11 restrains NCC migration and inﬂuences twist expres-
sion, which can be rescued by co-injection of β-catenin, indicating
that Wnt/β-catenin signaling is required to maintain twist expres-
sion (Borchers et al., 2001). By loss of function analysis we could
show that Xcadherin-11 initiates ﬁlopodia and lamellipodia for-
mation in Xenopus NCCs, acting upstream of the GTP exchange
factor (GEF) Trio and the small GTPases RhoA, Rac1 and cdc42
(Kashef et al., 2009).
In this study we report a novel function of the cell–cell adhesion
protein Xcadherin-11 in NCC speciﬁcation by regulating a precise
level of β-catenin within NCCs. Loss of Xcadherin-11 leads to the
accumulation of β-catenin within the nucleus of NCCs activating the
expression of the Wnt/β-catenin target genes cyclin D1 and c-myc.
This leads to an enhanced cell proliferation that can be rescued by
HUA treatment. The proliferation is followed by an expansion of NCC
marker gene expression and reduced expression of neural marker
genes. Since broadening of cyclin D1 expression precedes c-myc up-
regulation we conﬁrm c-myc as neural crest speciﬁer and identiﬁed
cyclin D1 as regulator of neural crest proliferation.
Materials and methods
Constructs
Xcadherin-11 and deletion constructs as well as Gap43-GFP
(mbGFP) were described previously (Borchers et al., 2001; Kashef
et al., 2009). Xcadherin-11 morpholino antisense oligonucleotide
(Xcad-11-MO) and β-catenin-MO were designed as previously
characterized (Heasman et al., 2000, Kashef et al., 2009) and
purchased from Gene Tools, LLC.
Embryo micromanipulation, lineage tracing and in situ hybridization
Xenopus laevis embryos were obtained by in vitro fertilization
and staged according to Nieuwkoop and Faber (1967). RNA for
injection experiments was synthesized in vitro using mMessage
mMachine Kit (Ambion). To identify the injected side dextran-FITC
(4 pg; Molecular Probes) or membrane bound GFP (mbGFP, 200 pg
mRNA) were used as lineage tracer.
In situ hybridization (ISH) was described earlier (Harland,
1991). Digoxigenin-labeled antisense RNA was generated accord-
ing to manufacturer's (Roche) description using template cDNA
encoding c-myc (Bellmeyer et al., 2003), cyclin D1 (Vernon and
Philpott, 2003), sox2 (Mizuseki et al., 1998), N-CAM (Kintner and
Melton, 1987), AP-2 (Luo et al., 2003), sox10 (Aoki et al., 2003),
krox-20 (Bradley et al., 1993) and en2 (Landesman and Sokol,
1997). Results of at least three independent experiments were
averaged, and statistical signiﬁcance was calculated by using
Student's t-test.
Hydroxyurea and aphidicolin treatment was performed as
described elsewhere (Saint-Jeannet et al., 1997, Aybar et al.,
2003). Embryos were incubated in HUA solution between stage
12 and 19.
Quantitative real-time-PCR (qRT-PCR)
For qRT-PCR embryos were injected in the animal dorsal
blastomeres bilaterally in eight-cell-stage embryos. RNA was
extracted from groups of ﬁve embryos of the recommended stage
by using the High Pure RNA Isolation Kit (Roche). 150 ng of total
RNA was reverse transcribed (M-MLV, Promega). cDNA was sub-
jected to 40 cycles of PCR at an annealing temperature of 57 1C or
60 1C with primers as described (Suppl. Table 1). Expression levels
were calculated relative to ornithine decarboxylase (ODC) and were
normalized to uninjected controls. Results of at least three
independent experiments were averaged, and statistical signiﬁ-
cance was calculated by using Student's t-test.
Immunohistochemistry
Embryos were injected with 16 ng Xcad-11-MO into the animal
hemisphere of one dorsal blastomere at eight-cell-stage unless
described differently. Proliferation was estimated by phospho-
histone H3 detection, as described earlier (Kunz et al., 2004). For
β-catenin staining embryos were ﬁxed in MEMFA. Cryosections of
embryos were described earlier (Fagotto and Brown, 2008).
Transverse sections of 12 μm were cut with a cryotome (CM
1900, Leica). The sections were washed three times with 1APBS
and pre-incubated in blocking solution (1APBS, 10% FCS, 1%
blocking reagent (BMB, Roche)) for 1 h (room temperature). The
undiluted primary antibody was applied to the sections over night
at 4 1C. Following three washing steps in 1APBS, sections were
treated with secondary antibody (goat-anti-rat)-Cy3 (Dianova),
1:200 diluted in blocking solution for 1 h at 37 1C. Sections were
washed twice and treated for 5 min with DAPI (0.4 μg/ml in
1APBS) to visualize the nuclei. Sections were mounted in
mowiol. Images were taken with an Axio Observer.Z1 Spinning
Disc confocal microscope (Carl Zeiss AG) using 63 LCI-Neoﬂuar-
Imm-Corr-DIC objective (na 1.3) and 5 Plan-Apochromat (na 0.16)
and analyzed with the AxioVision software (4.7.2).
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Statistical analysis of pH3 staining
ISH staining of c-myc or AP2 was performed to identify NCC
tissue. Afterwards, embryos were cryosectioned and immunos-
tained for phospho-histone H3. The area of NCC tissue was
identiﬁed by the blue color from ISH staining. This area was
selected as region of interest (ROI) and its volume was calculated
by ImageJ software (version 1.46a). The number of pH3 positive
nuclei was counted within ROI. To countervail biased measure-
ments due to skewed section planes, the results of all sections of
one embryo were accumulated that it resembled the whole mount
measurements. Results of at least three independent experiments
were averaged, and statistical signiﬁcance was calculated by using
Student's t-test.
Keller open-face explants assay
Embryos were injected with Xcad-11-MO (16 ng) alone or
together with Xcad11Δc or Xcad11Δe in both dorsal blastomeres
at four-cell stage. For analysis of convergent extension movements
Keller open-face explants were prepared at stage 10.5 and cul-
tured, imaged and scored as described previously (Keller, 1991;
Unterseher et al., 2004). The results of at least three independent
experiments were averaged, and statistical signiﬁcance was calcu-
lated using Student's t-test.
Luciferase assay
Embryos were injected in one dorsal animal blastomere of
eight-cell-stage with mbGFP for tracing and luciferase reporter
constructs (cyclin D1 promoter (Tetsu and McCormick, 1999),
siamois promoter (Brannon et al., 1997)) with or without Xcad-
11-MO. As positive control constitutive active β-catenin (Aberle
et al., 1997) was injected. At neurula stages NCCs were explanted.
20 NCC explants were collected and lysed in 25 ml 50 mM Tris–HCl
(pH 7.5). The lysat was centrifuged and the supernatant was
supplemented with additional 25 ml Tris–HCl and 210 ml reporter
lysis puffer (luciferase assay kit, Promega). Samples were freeze-
thawed in liquid nitrogen, centrifuged and resulting supernatant
was analyzed for luciferase activity (20 ml sample with 100 ml
luciferin reagent, 30 s incubation, 10 s measurement). Samples
were normalized against protein concentration as determined by
standard BCA assay. Results of at least three independent experi-
ments were averaged and statistical signiﬁcance was calculated by
using Student's t-test.
Results
Depletion of Xcadherin-11 induces c-myc and cyclin D1 expression
In a previous study we observed an increase in cell proliferation
and an increase of neural crest cells (NCCs) after depletion of
Xcadherin-11 by injection of an antisense morpholino nucleotide
(MO) (Kashef et al., 2009). In order to investigate this observation
more closely we asked whether cyclin D1 and c-myc, two
regulators of cell proliferation known to be expressed in NCCs
(Bellmeyer et al., 2003, Vernon and Philpott, 2003), are increased
in Xcadherin-11 morphants. Indeed, whole-mount ISH of embryos
injected with 8 ng Xcad-11-MO in one blastomere of eight-cell-
stage revealed an expansion of cyclin D1 expression (Fig. 1A,B).
58% (78.9, n¼38) of the embryos at stage 16 and 61% (71.6,
n¼33) at stage 19 showed a broader and partially posteriorly
shifted cyclin D1 expression domain (Fig. 1A,B). The expression of
c-myc was slightly altered in a different manner. At stage 16 we
observed in 35% (71.9, n¼46) of the embryos a more diffuse and
broader expression of c-myc while 41% (75.1) of the embryos
displayed no change in the expression area (Fig. 1A,B). Interest-
ingly, at stage 19 the expression of c-myc was dramatically
increased on the injected side in the majority of the embryos
(61%, 74.7, n¼63). To get more quantitative data about the
expression levels of cyclin D1 and c-myc after Xcadherin-11
depletion we performed qRT-PCR with whole embryos that have
been injected with Xcad-11-MO in two animal dorsal blastomeres
of an eight-cell-stage embryo. Consistent with the ISH data
(Fig. 1A), expression of cyclin D1 was clearly up-regulated at
developmental stage 19 and also at stage 25 (128%; p¼0.0001
and 195%, p¼0.06; Fig. 1C) while at stage 16 the expression was
unchanged compared to uninjected embryos indicating that the
broadening of the expression observed in the ISH does not
represent an increased expression in this neurula stage. This might
be attributed to the differences in the methods; in qRT-PCR
experiments the spatial resolution is ignored. For c-myc the qPCR
data resembled the ISH data (Fig. 1A,B). Again, an increase in
expression could be observed in stage 19 and 25 embryos (142%,
p¼0.03 and 177%, p¼0.1) while at stage 16 the expression of the
majority of the embryos was unaltered. However, both, ISH and
qRT-PCR revealed that the expression of the NCC speciﬁc regula-
tors of cell proliferation, c-myc and cyclin D1, is increased from
stage 19 in NCCs lacking Xcadherin-11.
Loss of Xcadherin-11 increases cell proliferation
In principle, the observed expansion in cyclin D1 and c-myc
expression might be resulting from changes in cell fate decisions
leading to more NC speciﬁcation. Alternatively, since cyclin D1 and
c-myc are well characterized regulators of cell proliferation this
mechanism might result in increased proliferation in NC area as
indicated earlier by increased pH3 staining in Xcad-11 depleted
embryos (Kashef et al., 2009). As seen by staining of mitotic nuclei
in NC positive tissue the size of neural crest area and number of
pH3 positive cell nuclei increased simultaneously (Suppl. Fig. 1),
meaning the relative number of mitotic cell nuclei is unaltered.
This indicates that both possibilities, involvement of cell fate
changes or proliferation, can lead to an expansion of NC tissue.
To further analyze the role of proliferation on neural crest
development by Xcad-11 depletion we repeated the Xcadherin-11
knockdown and incubated the embryos in the presence of the
inhibitors of proliferation hydroxyurea and aphidicolin (HUA)
(Saint-Jeannet et al., 1997; Aybar et al., 2003). In case of proliferation
being responsible for the observed phenotype, treatment of
Xcadherin-11 depleted embryos with HUA should rescue the
expansion of c-myc and cyclin D1 staining in stage 19. Indeed, we
observed a signiﬁcant reduction in the number of embryos showing
a broader expression domain of c-myc from 62% (75.2, n¼49,
Fig. 2A,B) when Xcadherin-11 depleted embryos were treated only
with DMSO to 31% (73.7, p¼0.0008, n¼84; Fig. 2A,B) when
treated with HUA. The number of embryos with broader c-myc
expression in DMSO treated embryos is in a similar range than in
not-DMSO treated injected embryos (61%, see Fig. 1). Similarly, the
number of embryos with an expanded expression domain of cyclin
D1 was reduced from 49% (73.3; n¼63) to 27% (75.3; p¼0.02;
n¼75). To conﬁrm the functionality of HUA treatment in Cad-11 Mo
injected embryos we analyzed pH3 staining after DMSO or HUA
incubation. While treatment with DMSO did not interfere with
proliferation and resulted in a high number of pH3 positive nuclei
in the entire embryo treatment with HUA led to a nearly complete
loss of cell proliferation (Suppl. Fig. 1D). This indicates that
Xcadherin-11 depletion results in an increase of cell proliferation
in NCC tissue.
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Loss of Xcadherin-11 induces NCC speciﬁcation
C-myc is one of the earliest NCC speciﬁers and is required for the
initial induction of NCC precursors (Bellmeyer et al., 2003). Thus, we
asked whether the increase of c-myc expression after Xcadherin-11
depletion lead to an altered expression of other NCC marker genes
which have been described to be regulated by c-myc. Using qRT-PCR
we compared the expression of AP2 and sox10 between wildtype
and Xcadherin-11 morphants through different developmental
stages (stage 16, 19 and 25) (Fig. 3C). At stage 16 the expression
levels of AP2 were signiﬁcantly increased (160%, p¼0.02). At stage
19 we monitored still a slight increase in AP2 expression (122%,
p¼0.068), while at stage 25 the expression was not altered in
morphants in comparison to wildtype embryos. In contrast, the
expression of sox10, a temporally later expressed NCC marker than
AP2, was reduced in stage 16 and signiﬁcantly decreased in
Xcadherin-11 depleted embryos at stage 19 (42%, p¼0.03). At tail
bud stage we detected a distinct increase of sox10 transcripts in
Xcad-11-MO injected embryos (139%, p¼0.16). We further con-
ﬁrmed these ﬁndings by ISH (Fig. 3A,B). Xcadherin-11 morphants
showed a broadening of AP2 expression in stage 16 (52%, 77.8,
n¼53) and 19 (46%, 73.7, n¼79) while at stage 25 the expres-
sion domain was unaltered or slightly increased (44%, 79.1, n¼53).
In comparison, sox10 expression was ﬁrst decreased at stage 16 and
19 (60%, 75.0, n¼32 and 70%, 75.7, n¼34) and later increased
(42%, 74.0, n¼30) at the Xcad-11-MO injected side (Fig. 3B). Taken
together, these results indicate a subsequent activation of NCC
marker genes following c-myc activation.
Xcadherin-11 is additionally expressed during gastrulation
(Hadeball et al., 1998). Therefore, the depletion of Xcadherin-11
could have an inﬂuence on early NCC induction steps due to
disturbed gastrulation movements that cause a shift of inductive
ﬁelds, which are important for proper NCC induction. To examine
this possibility we injected Xcad-11-MO into both dorsal blasto-
meres at four-cell-stage and analyzed the blastopore closure during
gastrulation from stage 11 to stage 12 (Suppl. Fig. S2A). Here, we
observed a delay of blastopore closure in Xcadherin-11 morphants.
To analyze more intensively gastrulation movements we performed
Keller open-face explants (Keller, 1991). Interestingly, the depletion
of Xcadherin-11 had no inﬂuence on constriction but on the
elongation of Keller open-face explants. 19% (71, n¼75) of Xcad-
11-MO injected explants exhibited a reduced elongation (Suppl. Fig.
S2B,C). To determine whether the adhesive or the signaling function
of Xcadherin-11 is necessary for proper gastrulation movements we
performed rescue experiments by co-injections of Xcadherin-11
lacking the extracellular (Xcad-11Δe, also see Fig. 4A) and
Fig. 1. Depletion of Xcadherin-11 increases c-myc and cyclin D1. (A) Whole mount ISH results of Xcad-11-MO (8 ng) injected (*) in one dorsal animal blastomere of eight-
cell-stage embryos analyzed at stage 16 and 19 for cyclin D1 and c-myc expression (dorsal view, anterior to top). Expression area of cyclin D1 is increased in both stages,
whereas c-myc expression seems to be ﬁrst unaffected at stage 16 and subsequently broadend at stage 19. (B) Statistical analyses of whole mount ISH results for cyclin D1
and c-myc. (C) qRT-PCR comparing cyclin D1 and c-myc expression between uninjected and Xcad-11-MO injected embryos at stage 16, 19 and 25. The expression of cyclin D1
and c-myc is increased in stage 19 and even more in stage 25. n¼number of embryos (*pr0.1; **pr0.05).
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Xcadherin-11 lacking the cytoplasmic domain (Xcad-11Δc) together
with Xcad-11-MO. Interestingly, only Xcad-11Δc could rescue the
elongation phenotype demonstrating the prominent adhesive func-
tion of the extracellular domain of Xcadherin-11 during convergent
extension movements. Since we observed only a weak gastrulation
phenotype and additionally injected in all experiments at eight-cell
stage to target speciﬁcally NCCs we can propose that the observed
effects of Xcadherin-11 depletion on NCC formation were not due to
changes in early NCC induction processes by cell signaling events
from the dorsolateral mesoderm during gastrulation. Instead, knock-
down of Xcadherin-11 led to changes in cell speciﬁcation during
NCC induction by affecting c-myc expression. Furthermore, the
restricted gastrulation movements per se were not affecting NCC
induction.
The expansion of NCC tissue in response to Xcadherin-11 knock-
down raised the question whether other cell fates are altered as well.
Therefore, we analyzed the expression of neural markers that are
closely related to NCC development. The expression of the pan-
neurally expressed sox2 resulted in a diffuse broadening of the
expression domain in stage 16, 19 and 25 (Suppl. Fig. S3A,B). This
effect became most obvious in stage 16 (87%, 76.7, n¼50). The
intensity seemed to be decreased and we could conﬁrm this by qRT-
PCR analysis (Suppl. Fig. S3C,D). The expression of sox2 and another
neural marker, N-CAM, is reduced signiﬁcantly (67%, p¼0.02 and 63%,
p¼0.02) in Xcadherin-11 depleted embryos at stage 19. To see
whether brain patterning is disturbed resulting in altered NCC
induction areas we also analyzed krox-20 (rhomomere 3 and 5) and
en2 (marking the mid-hindbrain boundary) expression by in situ
hybridization. Both markers showed a strong decrease in expression in
stage 16 and krox-20 remained diminished until stage 25 underlying
the further observed decrease of neural tissue (Suppl. Fig. S3A,B).
The cytoplasmic domain of Xcadherin-11 mediates proper NCC
speciﬁcation
The surprising increase of cyclin D1 and c-myc in NCC tissue
prompted us to investigate the underlying molecular mechanism.
We asked whether the cell-cell adhesion function or the signaling
function of Xcadherin-11 is responsible to trigger proliferation.
Therefore we took advantage of different deletion mutants (Fig. 4A)
and co-injected them together with the Xcad-11-MO. These recon-
stitution experiments clearly demonstrated that the cytoplasmic tail
but not the extracellular domain could substitute for the loss of full-
length cadherin (Fig. 4). C-myc expansion by Xcad-11-MO (61% of the
embryos, 74.7, n¼63 was restored by full length Xcadherin-11
(26%, 76.5; n¼66, p¼0.004) and Xcad-11Δe (31%, 77.3; n¼60,
p¼0.017) but not by Xcad-11Δc (47%, 75.7, n¼56; Fig. 4A–C).
Consistently, proliferation in the NCC area as measured by area of
AP2 or c-myc stained tissue sections and by pH3 staining in
Xcadherin-11 morphants was reduced by co-injected Xcad-11Δe
from 2fold (70.2, n¼22) and 1.8fold (70.27), respectively to 1.2fold
(70.45, n¼13; p¼0.0059) and 1fold (70.41, p¼0.045), respectively
but not by Xcad-11Δc (2.1fold, 70.37, n¼24; and 1.5fold, 70.21;
Fig. 4D,E). Thus, signaling by the cytoplasmic tail, but not adhesion
via the extracellular cadherin domains is essential for regulation of
proliferation in the NCC area. A candidate region within the cyto-
plasmic tail, which could mediate such a regulation, is the binding
domain of the Wnt effector protein β-catenin. If this region, indeed,
is essential, depletion of the β-catenin binding site in the Xcad-11Δe
construct should result in a mutant unable to restore normal NCC
marker expression in Xcadherin-11 morphants. This is exactly what
we observed (Fig. 5). 68% (713.5, n¼63) of the Xcadherin-11
morphants showed a broader c-myc expression domain, even after
Fig. 2. Expanded c-myc and cyclin D1 expression domains result from increased proliferation. Xenopus embryos were injected with Xcad-11-MO in one dorsal animal
blastomere of eight-cell-stage embryo and incubated in DMSO only or in HUA/DMSO from stage 12–19. (A) Depletion of Xcadherin-11 results in expanded expression
domains of cyclin D1 and c-myc. (B) Statistical analysis of cyclin D1 and c-myc expression in Xcad-11 depleted embros tretated with DMSO or DMSO/HUA. Treatment with
HUA was able to rescue the expansion signiﬁcantly. (*pr0.05; **pr0.01; ***pr0.005) Injected side is marked with asterisk (*).
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co-injection of the β-catenin binding mutant (ΔeΔβcat, Figs. 4A,5A,B).
The results could be conﬁrmed by a broader staining of AP2 in 53%
(75.6, n¼63) and of c-myc in 67% (76.8, n¼63) of Xcad-11-MO
injected embryos co-injected with Xcad-11ΔeΔβcat (Fig. 5A,B). There-
fore, we hypothesized that β-catenin is released from the membrane
in Xcadherin-11 morphants and may signal as transcriptional co-
activator.
Xcadherin-11 reduction results in activation of canonical
Wnt-pathway
To prove this hypothesis, we analyzed the subcellular localiza-
tion of β-catenin after Xcadherin-11 depletion (Fig. 6). To target
the NCCs Xenopus embryos were injected with Xcad-11-MO and
mbGFP at eight-cell-stage into one animal dorsal blastomere
(Fig. 6A,C). At stage 19 embryos were ﬁxed, transversally sectioned
and analyzed for β-catenin staining (Fig. 6D–F). On the uninjected
side β-catenin is prominently localized at cell-cell contacts
(Fig. 6E). Besides its localization at cell–cell contacts, we could
ﬁnd β-catenin on the Xcad-11-MO injected side additionally
accumulated within several nuclei (Fig. 6F, arrows). A statistical
analysis (Suppl. Fig. 4) of several sections for the ratio between β-
catenin positive nuclei and total cell nuclei revealed a signiﬁcant
increase in nuclear localization of β-catenin on the injected side of
Xcadherin-11 depleted embryos (35%, 73.9, n¼142 DAPI-positve
nuclei) compared to the uninjected side (15%, 70.6, n¼131 DAPI-
positve nuclei, p¼0.007). These results displayed that after
Xcadherin-11 depletion β-catenin gets translocated within the
Fig. 3. Xcadherin-11 knockdown increases cranial NCC marker gene expression. (A) Whole mount ISH. Embryos were injected (*) with Xcad-11-MO (8 ng) in one dorsal
animal blastomere of eight-cell-stage and analyzed at stage 16 and 19 (dorsal view, anterior to top) as well as stage 25 (lateral view) for AP2 and sox10 expression. At all
stages investigated Xcadherin-11 morphants showed an increased AP2 expression. In comparison, almost all embryos revealed a reduced sox10 expression at stage 16 and 19
whereas at stage 25 most of the Xcad-11-MO injected embryos exhibited a broader expression domain of sox10. (B) Statistical analyses of whole mount ISH results for AP2
and sox10. (C) qRT-PCR analysis of AP2 and sox10 expression in stage 16, 19 and 25. We observed an increased expression of AP2 in stage 16 and 19 while sox10 was reduced
in stage 19 and became increased in the later stage. n¼number of embryos (*pr0.1; **pr0.05).
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nucleus and is possibly activating target gene expression as
transcriptional co-activator.
If the observed translocation of β-catenin to the nucleus is
responsible for the observed effects on cell proliferation and
marker gene expression the activation of the canonical Wnt-
signaling pathway should be one result of Xcad-11-MO injec-
tion. This inﬂuence of increased nuclear β-catenin on canonical
Wnt-signaling was tested by activation of Wnt dependent
reporter genes. We injected Xcad-11-MO or constitutively active
β-catenin together with mbGFP as lineage tracer and a siamois
or a cyclin D1 promoter fused to luciferase as reporter into one
animal dorsal blastomere of an eight-cell-stage embryo
(Fig. 7A). At neurula stage the NCCs were explanted and
analyzed by luciferase assay. The siamois promoter was acti-
vated 6.8fold (71.51; p¼0.0006, n¼4) by Xcad-11-MO in a
similar manner as by constitutively active β-catenin (6.4fold,
71.12; p¼0.0032, n¼3; Fig. 7B). The cyclin D1 promoter could
be activated even 20.5 fold by Xcad-11-MO (711.3, p¼0.0466,
n¼5) while β-catenin activated 4.6fold (71.5; p¼0.0146,
n¼6; Fig. 7C).
To prove the conclusion drawn by the earlier experiments
that the activation of canonical Wnt-signaling pathway is
responsible for the observed phenotype we performed the
experiments in β-catenin-MO background. We injected Xcad-
11-MO alone or together with β-catenin-MO and compared the
expression of NCC markers c-myc and AP2. As expected, the
blocking of the Wnt-pathway prevented the increased expres-
sion domain of AP2 and c-myc by injection of Xcad-11-MO
(Fig. 7D F). Compared with Xcadherin-11 morphants without β-
catenin-MO the number of embryos with broader expression of
the NCC markers was signiﬁcantly reduced. As expected and
previously shown (Hong et al., 2008), the injection of β-catenin-
Fig. 4. The cytoplasmic domain of Xcadherin-11 mediates proper c-myc expression and proliferation. (A) Scheme of the Xcadherin-11 mutants used for rescue experiments.
(B) Statistical analysis of whole mount ISH results for c-myc. Full length Xcad-11 and Xcad-11Δe, but not Xcad-11Δc co-injection was able to rescue c-myc expression.
(C) Whole mount ISH. Embryos were injected with Xcad-11-MO (8 ng) alone or together with 75 pg full length Xcad-11, 75 pg Xcad-11Δc or 50 pg Xcad-11Δe, respectively,
and analyzed for c-myc expression at stage 19. Dorsal view, anterior to top, asterisk marks the injected side. (D) Statistical analyses of whole mount ISH results. The area of
c-myc stained tissue was compared in horizontally sliced embryos. The area of NCC positive tissue is increased by Xcad-11-MO, and this effect cannot be reverted by co-
injection of Xcad-11 Δc. On the other hand co-injection of Xcad-11 Δe resulted in an area of a comparable size (1.2fold increase) as in uninjected tissue (set as 1).
(E) Statistical analysis of pH3 positive nuclei at stage 19 in NCC positive tissue. PH3 positive nuclei on the uninjected side were set as 1. The increase of pH3 positive nuclei
after Xcadherin-11 depletion could be signiﬁcantly rescued after Xcad-11Δe co-injection. Only 1.05fold of pH3 positive nuclei could be detected by immunohistochemistry. Co-
injection of Xcad-11Δc was not able to restore the increase of pH3 positive nuclei and resulted in an increase in mitotic nuclei by 1.52fold. n¼number of sections (*pr0.05).
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MO alone resulted in a decrease or complete loss of NCC tissue
(Fig. 7D–F).
Discussion
Cadherins are not just mediating cell-cell adhesion to organize a
proper tissue organization. Additionally, they have a prominent role
in cell migration and cell differentiation (Geiger and Ayalon, 1992;
Wollner et al., 1992, Takeichi, 1995; Becker et al., 2012). In this study
we show an unexpected function of the classical type II Xcadherin-11
in NCC speciﬁcation. Loss of Xcadherin-11 protein function led to an
accumulation of β-catenin within the nucleus and to an increased
expression domain of c-myc and cyclin D1, which are both direct
target genes of the canonical Wnt-signaling pathway and expressed
in Xenopus NCCs (He et al., 1998; Shtutman et al., 1999; Bellmeyer
et al., 2003; Vernon and Philpott, 2003). Additionally, depletion of
Xcadherin-11 induces the expression of early NCC speciﬁers with a
simultaneous decrease of neural marker genes. Furthermore, we
identiﬁed the C-terminal β-catenin binding site to be essential for
regulation of NCC speciﬁcation and proliferation by modulating a
balanced nuclear β-catenin level and therefore regulating Wnt/β-
catenin signaling. Importantly, the critical time-point for a balanced
nuclear β-catenin pool coincides with neural crest proliferation and
speciﬁcation (stage 16) but not with induction during gastrulation
(stage 11) as demonstrated by the different rescue constructs.
The development of NCC compromises the processes of induction,
maintenance, migration and differentiation (Steventon et al., 2005).
These studies proposed a novel, two-step model for NCC develop-
ment where increasing levels of Wnt and inhibition of BMP are
required at gastrula stages for NCC induction, whereas at neurula
stages constant high levels of Wnt and BMP are essential for NCC
speciﬁcation and maintenance (Steventon et al., 2009). Xcadherin-11
is expressed in a two-phase manner (Fig. 8A). A moderate expression
can be detected at the time of gastrulation (stage 10), which
increases during neurulation and at the onset of NCC migration
(stage 18) (Hadeball et al., 1998). Therefore, early expression of
Xcadherin-11 could correlate with a function in gastrulation, due to
(1) the adhesive function of Xcadherin-11 during convergent exten-
sion movements or (2) the signaling function by interference with
the canonical Wnt/β-catenin pathway, which could lead to disturbed
NCC induction. The adhesive function of Xcadherin-11 is needed for
proper gastrulation movements (this work). However, from our data
we can exclude a role of Xcadherin-11 in cell signaling phase during
NCC induction, because we observed an expanded expression area of
the early NCC marker gene c-myc in stage 19 and stage 25 embryos
depleted for Xcadherin-11. This increased c-myc expression seems
not to depend on disturbed gastrulation movements which could
Fig. 5. The β-catenin binding site is essential for Xcadherin-11 function. (A) Whole mount ISH. Embryos were injected with Xcad-11ΔeΔβcat (50 pg) either with or without
Xcad-11-MO in one dorsal animal blastomere of eight-cell-stage and analyzed at stage 19 for c-myc and AP2 expression. While overexpression of Xcad-11ΔeΔβcat did not
result in a distinct phenotype the expansion of c-myc and AP2 staining by Xcad-11-MO could not be rescued by Xcad-11ΔeΔβcat. Dorsal view, anterior to top, asterisk marks
the injected side. (B) Statistical analysis of whole mount ISH results. 67% of the analyzed embryos with Xcad-11-MO and Xcad-11ΔeΔβcat showed an expanded c-myc
expression domain. The overexpression of Xcad-11ΔeΔβcat did not show any signiﬁcant phenotype (80% normal expression). Similar results were obtained for AP2 (53%
increased expression in embryos co-injected with Xcad-11-MO and Xcad-11 ΔeΔβ-cat). n¼number of embryos.
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cause a shift of inductive ﬁelds, that are important for proper NCC
induction. A recent study by Steventon and Mayor (2012) highlights
a new three-step model for NCC induction where at early gastrula-
tion Wnt signals need to be repressed for neural plate border
induction. At mid-gastrula activation of Wnt together with inter-
mediate BMP signals is required for NCC speciﬁcation and at early
neurula both BMP and Wnt are required for NCC maintenance.
Therefore, activation of the Wnt-pathway by Xcadherin-11 depletion
activates the expression of NCC speciﬁers like c-myc and AP-2
(Figs. 1 and 3). Overexpression of Xcadherin-11 is not affecting NCC
induction but is important for Wnt/β-catenin signaling for late
events in NCC development. In particular, Xcadherin-11 is needed
for the maintenance of the NCC marker twist during the period of
NCC speciﬁcation (Borchers et al., 2001). Therefore, both loss of
function and gain of function experiments allocate Xcadherin-11
a role in NCC speciﬁcation.
The expression of Xcadherin-11 is induced by canonical Wnt-
signaling (Hadeball et al., 1998). Posttranslationally, the expression
of Xcadherin-11 can be modulated by proteases of the ADAM
matrix-metalloprotease family, namely ADAM13, which is
Fig. 6. β-catenin is translocated in the nucleus after Xcadherin-11 depletion. Transversal sections of Xcad-11-MO injected (one dorsal animal blastomere at eight-cell-stage)
embryos analyzed at stage 19. (A–C) Co-injection with mbGFP (200 pg) was used as lineage tracer and for membrane staining. (D–F) Immunostaining for β-catenin. Note
nuclear β-catenin staining at the injected side (red arrows in F). (G–I) Nuclei were stained with DAPI. (J–L) Merged images, squares indicate areas of higher magniﬁcation.
Crop1: uninjected side, crop2: injected side. Scale bar 50 mm.
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Fig. 7. Depletion of Xcad-11 results in an activation of the Wnt-signaling pathway. (A) Scheme of reporter gene experiment. Embryos were injected with the displayed
constructs in one dorsal animal blastomere of eight-cell-stage embryo. At neurula stages the NCC area was explanted and underwent luciferase assay. (B,C) Injection of Xcad-
11-MO resulted in strong activation of the siamois (B) and cyclin D1 (C) promoters. While the siamois promoter was activated in a similar manner by constitutively active
β-catenin as positive control and Xcad-11-MO, the increase in cyclin D1 expression was even more prominent in Xcad-11-MO injected embryos (*pr0.05; **pr0.01;
***pr0.005). (D) Enhanced expression of c-myc and AP2 by Xcad-11-MO can be prevented by co-injection of β-catenin-MO. (E,F) Statistical analysis of ISH. In Xcad-11-MO
injected embryos 63% of the embryos show an increased expression domain of AP2 (E) and 44% of c-myc (F). When β-catenin-MO was co-injected, only 29% of the embryos
resulted in an increased AP2 and only 24% in an increased c-myc expression area. (**pr0.01) β-catenin-MO injection alone led to decreased NCC formation.
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expressed in NCCs from stage 13 onward (Alfandari et al., 2001).
Although it has been shown that speciﬁc cleavage of Xcadherin-11
by ADAM13 starts with onset of NCC migration (McCusker et al.,
2009), other metalloproteases like ADAM9 may overtake the role
of early regulation of Xcadherin-11 localization to the membrane.
On the other hand ADAM13 enhances canonical Wnt-signaling
required for NCC induction (Wei et al., 2010, 2012). This indicates a
regulatory loop of canonical Wnt-signaling inducing Xcadherin-11
expression on the one hand and regulation of Wnt-signaling by
ADAM13 (Wei et al., 2010, 2012) and Xcadherin-11 (this paper).
Whether the regulation of Wnt via ADAM13 is a direct regulation
or mediated by Xcadherin-11 needs to be clariﬁed.
As it has been described for E-cadherin the binding of β-catenin
to the corresponding binding site of the cadherin inhibits the
simultaneous binding of β-catenin to transcription factors of the
LEF/TCF family (Orsulic et al., 1999). Thus, there are different
possible mechanisms of interacting with the canonical Wnt-
signaling pathway. (1) One idea is the shedding of the cadherin
leading to mobilization of the cytoplasmic domain which can
translocate into the nucleus and co-transport β-catenin for a
stronger induction of Wnt signal as it is described for N-
cadherin (Shoval et al., 2007). (2) On the other hand the binding
of β-catenin to the membrane bound or also mobilized cytoplas-
mic tail after ADAM cleavage might still keep β-catenin from
binding to LEF/TCF transcription factors. Since we observe a strong
activation of Wnt-signaling in luciferase reporter assays this seems
to support the former idea. In a similar way E-cadherin shedding
by ADAM10 also enhances Wnt-signaling and leads to increased
expression of cyclin D1 (Maretzky et al., 2005). The switch from
canonical to non-canonical Wnt-signaling by recruiting β-catenin
to Xcadherin-11 and thus eliminating it from the signaling path-
way may be one prerequisite for inducting NCC migration (De Calisto
et al., 2005).
Wnt/β-catenin is required for NCC speciﬁcation and mainte-
nance during Xenopus neurulation (Steventon et al., 2009). One of
the key mediators of the canonical Wnt-signaling pathway is β-
catenin, which gets accumulated within the nucleus after Wnt
response activating different target genes (Moon et al., 2002, Klaus
and Birchmeier, 2008). Due to their β-catenin binding site within
the cytoplasmic domain cadherins can compete with the canonical
Wnt-signaling pathway for β-catenin. Studies in Xenopus demon-
strated that overexpression of cadherins led to an inhibition of
dorsal axis formation what is a clear function of canonical Wnt-
signaling (Heasman et al., 1994; Fagotto et al., 1996). Additionally,
E-cadherin-/- embryonic stem cells displayed an accumulation of
β-catenin in the nucleus and the activation of a Wnt reporter
(Orsulic et al., 1999). Moreover, the overexpression of Xcadherin-
11 led to posteriorized phenotypes with strong head defects,
which could be rescued by co-injection of β-catenin (Hadeball
et al., 1998). In this study, we could detect a nuclear localization of
β-catenin after depletion of Xcadherin-11, which is underlying the
competition of cadherins and canonical Wnt-signaling pathway
for β-catenin resulting in an increased expression domain of the
Wnt/β-catenin target gene and NCC speciﬁer c-myc as we could
also demonstrate by siamois and cyclin D1 reporter gene activa-
tion. A similar mechanism was recently shown for E-cadherin,
where its down-regulation activates β-catenin/TCF dependent
transcription, which subsequently leads to the expression of c-
myc (Wang et al., 2010). We were able to rescue the increase of c-
myc expression by co-injection of the membrane anchored cyto-
plasmic tail of Xcadherin-11. Interestingly, we failed to rescue this
phenotype by co-injecting this construct lacking the β-catenin
binding site (Xcad-11ΔeΔβcat). More important, we were able to
rescue the increase in c-myc expression in a β-catenin deﬁcient
background (Fig. 7D–F). Additionally, the loss of β-catenin alone
led to loss of c-myc expression and NCC formation (Fig. 7D–F).
These ﬁndings support again the Wnt⧸β-catenin dependent
expression of c-myc and the competition for β-catenin between
the cytoplasmic tail of Xcadherin-11 and the canonical Wnt-
signaling pathway (He et al., 1998).
Simultaneously with an expanded c-myc expression we
observed an increase in cell proliferation. C-myc plays an important
role in cell cycle progression by regulating cyclin D2 expression and
by inﬂuencing the stability and activity of cyclin/cdk-complexes
(Steiner et al., 1995; Mateyak et al., 1999; Bouchard et al., 2004;
Chiles, 2004). However, in Xenopus c-myc is a key regulator of NCC
speciﬁcation independent of NCC proliferation (Bellmeyer et al.,
2003). This is in line with our data. When we overexpressed c-myc
we could only detect a slight increase in cell proliferation (data not
shown). Furthermore, the broadening of the expression domain of
c-myc in Xcadherin-11 morphants is delayed compared to cyclin D1
which is expanded already in stage 16. Nevertheless, the develop-
ment of the quantitative expression level of c-myc and cyclin D1 is
similar. This indicates that the spatial induction of neural crest
Fig. 8. Model of Xcadherin-11 function in NCC speciﬁcation. (A) Temporal course of
Wnt and Xcadherin-11 protein levels during embryo development stages and the
corresponding phases of NCC formation (color code see Steventon et al., 2005).
Increased expression of Xcadherin-11 at neurula stages is correlated with an
increased Wnt level. (B) Competition of Xcadherin-11 and Wnt for the cytoplasmic
pool of β-catenin. Knockdown of Xcadherin-11 leads to increased levels of β-catenin
in the cytoplasm and an enhanced nuclear localization resulting in an up-
regulation of NCC speciﬁers c-myc and cyclin D1.
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inducers precedes the quantitative enhancement. Work on Droso-
phila reporting that mutations in c-myc fail to cause defects in cell
proliferation also support alternative c-myc functions (Johnston
et al., 1999). It is easily conceivable that the interference with cell
cycle control in Xcadherin-11 morphants must depend on addi-
tional target genes, which can be activated through β-catenin. We
identiﬁed cyclin D1, one of the main regulators in GI to S-phase
transition during the cell cycle (Baldin et al., 1993; Sherr, 1996). In
this study, knockdown of Xcadherin-11 resulted in a strong increase
in cyclin D1 expression through mostly all stages analyzed correlat-
ing with a simultaneous increase in cell proliferation allocating
cyclin D1 instead of c-myc a prominent role in NCC proliferation.
We signiﬁcantly rescued the increase in cell proliferation by co-
injection of the cytoplasmic domain of Xcadherin-11. This suggests
that the cytoplasmic domain could interfere with the canonical
Wnt-signaling pathway by recruiting the cytoplasmic pool of
β-catenin to the membrane and inhibiting cyclin D1 mediated cell
proliferation. Our data support former studies, which showed that
overexpression of β-catenin led to an increase of cyclin D1 expres-
sion whereas the overexpression of the cytoplasmic tail of N-
cadherin decreased protein levels of cyclin D1 (Shtutman et al.,
1999). However, comparing proliferation rate and neural crest tissue
size we could not distinguish between cell fate changes and cell
proliferation. Inhibition of proliferation is possible by hydroxyurea
and aphidicolin (HUA) which induce a rapid replication arrest
(Hammond et al., 2003). Thus, treatment of Xcadherin-11 depleted
embryos with HUA prevented the broadening of the c-myc expres-
sion domain proving the role of proliferation as a causal initiator of
the observed phenotype. Apart from increased cell proliferation
upon Xcadherin-11 depletion (Kashef et al., 2009, this manuscript)
recent studies in a murine retinoblastoma model revealed a
decrease in apoptosis in absence of cadherin-11 due to up-
regulation of β-catenin mRNA (Marchong et al., 2010). Thus,
cadherin-11 might suppress tumor growth context dependent
either by limiting cell proliferation or promoting apoptosis.
Besides c-myc we could observe an increased expression of the
NCC speciﬁer AP2. Recent studies highlighted the important
function of AP2 in initiating the neural border, inducing NCCs
and acting as a NCC speciﬁer. The authors demonstrated that AP2
is sensitive to Wnt-signaling (Luo et al., 2003) and acts down-
stream of c-myc (Bellmeyer et al., 2003; de Croze et al., 2011).
In our studies the increase in AP2 expression can be caused
directly by activated Wnt/β-catenin signaling or indirectly through
increased c-myc expression. In response AP2 is able to induce the
expression of later NCC marker genes like sox10, sox9 and snail2
and to inhibit expression of neural markers like sox2 (de Croze
et al., 2011). AP2 and c-myc are speciﬁers of neural plate border
(NPB) formation. While AP2 restricts NPB towards the ectoderm, c-
myc demarcates the neural tissue from NC. Both are expressed at
similar time points around stage 10 (Winning et al., 1991; Honoré
et al., 2003). Additionally, Schneider et al. (2010) revealed that
expression levels of AP2 and snail1 are regulated by c-myc. The
expression of sox10, which mediates speciﬁcation, and survival of
Xenopus NCCs (Honoré et al., 2003) is temporally subordinated to
c-myc and AP2 (Light et al., 2005; de Croze et al., 2011; Milet et al.,
2013) and it becomes prominent in the prospective NCC region in
stage 14 (O'Donnell et al., 2006; Milet et al., 2013) indicating
that sox10 is one of the late NC speciﬁers in the gene regula-
tory cascade. The observed delay in sox10 expression in our study
(Fig. 3B) could be caused by the expanded c-myc expression or by
the increased AP2 expression resulting in a delayed manifestation
of the neural plate border. Thus, in absence of Xcadherin-11 NCCs
still persist in the early speciﬁcation phase and temporally sub-
ordinated genes like sox10 are not yet expressed. Nevertheless,
sox10 has been reported to be a Wnt dependent target gene.
Overexpression of Wnt or of GSK-3β inhibitors results in an
increased expression of Sox10 (Aoki et al., 2003). Since depletion
of Xcad-11 leads to activation of Wnt signaling sox10 expression
should be increased. Due to its late position in the regulatory
network of NC induction and by the delay in the NC speciﬁcation
process the prospective NC ﬁeld remains in an early state thereby
preventing the expression of later speciﬁer genes. Dutton et al.
(2008) showed that the expression of Sox10 does not only depend
on Wnt signaling but that a combination with other transcription
factors is necessary which are also embedded in the genes
regulatory cascade. During progression of NCC speciﬁcation the
expression of Sox10 is then activated and enhanced. This results in
increased pigmentation in Xcadherin-11 depleted embryos
(Kashef et al., 2009) since later emigration from the neural tube
results in increased formation of melanocytes (Thomas and
Erickson, 2009).
Conclusion
Increasing levels of Wnt and inhibition of BMP are required at
gastrula stages for NCC induction, whereas at neurula stages
constant high levels of Wnt and BMP are essential for NCC
speciﬁcation and maintenance (Steventon et al., 2009). Therefore,
a balanced Wnt/β-catenin level is essential for NCC development.
In Xenopus, overexpression of dominant negative Wnt-8 leads to
loss of the expression of snail2. In contrast, β-catenin overexpres-
sion results in an increased and expanded expression of snail2 at
the expense of the neural plate marker sox2 (LaBonne and
Bronner-Fraser, 1998). This is similar to what we show after
Xcadherin-11 depletion. Interestingly, the increase of needed
Wnt-signaling for NCC speciﬁcation during neurulation is corre-
lated with the increase of Xcadherin-11 expression (Hadeball et al.,
1998). Apart from controlling cell migration Xcadherin-11 con-
tributes to balancing the nuclear β-catenin level by sequestering
cytoplasmic β-catenin to the membrane.
Taking our results together we propose following model for the
role of Xcadherin-11 in NCC speciﬁcation (Fig. 8): increased
expression of Xcadherin-11 at neurula stages is correlated with
an increased Wnt level (Fig. 8A). Xcadherin-11 normally recruits
β-catenin to the plasma membrane. After depletion of Xcadherin-11
β-catenin can translocate into the nucleus activating Wnt target
genes like cyclin D1 and c-myc. The increase of cyclin D1 is
correlated with an increase in proliferation, which lead to more
NCCs. In parallel, increase of the early NCC speciﬁer c-myc activates
the expression of other NCC genes like AP2 and sox10 (Fig. 8B).
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